Results

Total Results: 8,263 records

Showing results for "topical treatment".

  1. hcup-us.ahrq.gov/db/nation/kid/KIDIntroduction2022.pdf
    December 01, 2024 - large sample size enables analyses of rare conditions, such as congenital anomalies and uncommon treatments … sample size, which enables analyses of rare conditions (e.g. congenital anomalies) as well as, uncommon treatments … large sample size enables analyses of rare conditions, such as congenital anomalies and uncommon treatments … data), long-term non-acute care hospitals, psychiatric hospitals, and alcoholism/chemical dependency treatment
  2. digital.ahrq.gov/sites/default/files/docs/publication/r18hs017234-wagner-final-report-2011.pdf
    January 01, 2011 - Department of Health and Human Services of a particular drug, device, test, treatment, or other clinical … communication although these results were limited by procedural difficulties d. congruence of treatment … establish goals, track action toward those goals, manage medications, and coordinate other aspects of the therapeutic … Alternative Therapies in Health & Medicine,, 2006. 12(4): p. 62-70. 13. Kidd, J., Theresa M. … al,, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment
  3. www.ahrq.gov/sites/default/files/publications/files/interimhacrate2013_0.pdf
    October 27, 2014 - Algorithm enhances provision of preventive treatment to at-risk inpatients, reducing incidence of venous … https://innovations.ahrq.gov/profiles/algorithm-enhances-provision-preventive-treatment-risk-inpatients-reducing-incidence-venous … Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy … Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based … Antithrombotic therapy practices in US hospitals in an era of practice guidelines.
  4. hcup-us.ahrq.gov/reports/race/C18RECaseStudyReportforWEBfinal99.pdf
    January 01, 2020 - • The Institute of Medicine’s (IOM) Unequal Treatment: Confronting Racial and Ethnic Disparities … Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. … an array of health policy issues, such as health service costs and quality, health care access, and treatment … delivery at the local level by showing where improvements are needed in prevention, diagnosis and treatment
  5. hcup-us.ahrq.gov/reports/methods/2006_10.pdf
    January 01, 2006 - Table 4 demonstrates that ambulatory surgery care is strongly concentrated in treatments for only a … The ICD CCS category 214 was also paired with the CPT CCS category 144: treatment, facial fracture or … CCS Code CCS Group Description Percent 1 214 Traction; splints; and other wound care 49.0 2 144 Treatment … Debridement of wound; infection or burn 2.1 5 55,022 214 Traction; splints; and other wound care 5 147 Treatment … procedures 0.1 3 21 Other extraocular muscle and orbit therapeutic procedures 0.1 4 231 Other therapeutic
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_disposition-comments.pdf
    August 23, 2012 - With only 110 babies divided into 4 different treatment groups, this could be one of those studies
  7. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary2/healthy-diet-and-physical-activity-counseling-adults-with-high-risk-of-cvd-august-2014
    August 26, 2014 - protocol to start medication for dyslipidemia or increased glucose levels or to start nicotine replacement therapy … Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled … Motivational interviewing and problem solving treatment to reduce type 2 diabetes and cardiovascular … Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review
  8. www.ahrq.gov/sites/default/files/publications2/files/hac-cost-report2017.pdf
    November 01, 2017 - Exclusions English[lang] AND United States[pl] AND (2000:2017[dp] Adverse Drug Events ((“Drug therapy … Phenprocoumon”[mh] OR “Protein C”[mh] OR “Protein S”[mh] OR “Rivaroxaban”[mh] OR “Warfarin”[mh] OR “Hirudin Therapy … Surgical site infection: incidence and impact on hospital utilization and treatment costs. … 1.73) 1.47 (1.30-1.67) g Represents the number of instances of a major bleed in the presence of drug therapy … administration; some patients received more than one drug therapy.
  9. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/hac-cost-report2017.pdf
    November 01, 2017 - Exclusions English[lang] AND United States[pl] AND (2000:2017[dp] Adverse Drug Events ((“Drug therapy … Phenprocoumon”[mh] OR “Protein C”[mh] OR “Protein S”[mh] OR “Rivaroxaban”[mh] OR “Warfarin”[mh] OR “Hirudin Therapy … Surgical site infection: incidence and impact on hospital utilization and treatment costs. … 1.73) 1.47 (1.30-1.67) g Represents the number of instances of a major bleed in the presence of drug therapy … administration; some patients received more than one drug therapy.
  10. www.ahrq.gov/sites/default/files/publications2/files/dxsafety-issuebrief-education.pdf
    March 11, 2022 - into specific skills and practices regarding effective listening, teach-back, and strategies to build therapeutic … case presentations, but also repeated exposures to atypical presentations and other conditions and treatments
  11. hcup-us.ahrq.gov/reports/methods/2007_01.pdf
    January 01, 2007 - quality of health services, medical practice patterns, access to health care programs, and outcomes of treatments … To the extent that physicians uniquely affect patient therapy, health outcomes might be correlated … The key to HLM lies in the treatment of the clustering and the heterogeneity of the outcome. … If a patient obtained care on a Wednesday, the treatment and outcome could well have been different … (versus non-surgical treatment), and whether a patient is readmitted to the hospital within 30 days
  12. www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/primary-care-based-efforts.pdf
    March 01, 2019 - • The intervention group received calls from pharmacists who conducted a medication therapy assessment … • At these appointments, pharmacists identified drug therapy problems and worked to resolve these … 4.6 encounters per patient over 11 months • Pharmacists identified an average of 10.4 drug therapy … They identified drug therapy problems, including inappropriate medications, adverse reactions, difficulty … adhering to treatments, and financial barriers, and worked to resolve these problems with the retail
  13. www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/PrimaryCareEffortsToReduceReadmissions-envscan.pdf
    March 01, 2020 - • The intervention group received calls from pharmacists who conducted a medication therapy assessment … • At these appointments, pharmacists identified drug therapy problems and worked to resolve these … 4.6 encounters per patient over 11 months • Pharmacists identified an average of 10.4 drug therapy … They identified drug therapy problems, including inappropriate medications, adverse reactions, difficulty … adhering to treatments, and financial barriers, and worked to resolve these problems with the retail
  14. www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-final-report-b.pdf
    January 01, 2025 - Appropriate and timely treatment: Medication management; timely post-intervention; lifestyle monitoring … Select all content addressed during the interaction: • Evidence-based psychosocial care • Use of a treatment
  15. www.uspreventiveservicestaskforce.org/home/getfilebytoken/MzHhsgTBL37rRvvJfkfgMZ
    August 20, 2019 - were included to ensure that genetic testing was in- tended for risk reduction rather than treatment … . bIncludes women who may have a previous diagnosis of breast or ovarian cancer but have completed treatment … PDQ® Breast Cancer Treatment. 2013. https://www.cancer.gov/ cancertopics/pdq/treatment/breast/ healthprofessional … impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy … Multidisciplinary management of risk-reducing mastectomy and immediate reconstruction: treatment algorithm
  16. psnet.ahrq.gov/primer/coronavirus-disease-2019-covid-19-and-safety-older-adults
    April 10, 2024 - Covid-19 confusion: update on coverage for testing, treatment. The NCSL Blog . July 23, 2020.
  17. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/child-growth-development-outcomes-protocol.pdf
    August 19, 2024 - consumer education materials, such as the nutrition facts panels on food packaging, in medical nutrition therapy … relevant, allocation of subjects to exposure; report similar baseline characteristics in different treatment
  18. hcup-us.ahrq.gov/db/nation/neds/NEDS_Introduction_2011.jsp
    January 01, 2011 - Data Methods Series ICD-10-CM/PCS Resources Database Reports Additional Topics and Archives Topical … Records in the NEDS can be divided into ED visits that resulted in treatment and release (without a hospital … , (3) Major Diagnostic, (4) Major Therapeutic NPR_ED Number of procedures coded on the original … , (3) Major Diagnostic, (4) Major Therapeutic NPR_IP Number of procedures coded on the original … Patients who died on arrival to the ED or during treatment in the ED are excluded.
  19. hcup-us.ahrq.gov/db/nation/neds/NEDS_Introduction_2006.jsp
    January 01, 2006 - Data Methods Series ICD-10-CM/PCS Resources Database Reports Additional Topics and Archives Topical … PCLASS_ED1 – PCLASS_ED9 Procedure class for all ICD-9-CM procedures: (1) Minor Diagnostic, (2) Minor Therapeutic … , (3) Major Diagnostic, (4) Major Therapeutic NPR_ED Number of procedures coded on the original … , (3) Major Diagnostic, (4) Major Therapeutic NPR_IP Number of procedures coded on the original … Patients who died on arrival to the ED or during treatment in the ED are excluded.
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_technical-brief.pdf
    March 01, 2015 - Public reporting may also improve how health care resources are consumed by promoting the use of treatments … transparency is normally targeted before consumers seek care so they can be empowered to make informed treatment … , 2011 Agency for Healthcare Research and Quality Original Research X X Barlas, 2010 Pharmacy and Therapeutics … Pharmacy and Therapeutics 2010;35(7):369-372. Catalyst for payment reform. … Within these care settings, the vendors report on costs for medical treatments, procedures, imaging